News for OPKO Health, Inc. (OPK.MX)

Summary OPKO Health Inc (OPK) has announced the establishment of a Scientific Advisory Board for its subsidiary, ModeX Therapeutics, as of June 9, 2025. The boa

Will provide expertise across ModeX's portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including cancer

MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. ( OPK) announced today that management will be participating in two investor conferences over the co

Investment Highlights: OPKO Health is currently in oversold territory, potentially indicating a rebound opportunity. Analysts provide a wide price target

On May 1, 2025, Barrington Research analyst Michael Petusky reaffirmed his positive outlook on OPKO Health (OPK), maintaining an "Outperform" rating. The analys

Diagnostics Segment Revenue: $102.8 million in Q1 2025, including $25.1 million from assets being sold to LabCorp, compared to $126.9 million in Q1 2024.Diagno

Apr 30, 2025 / 08:30PM GMTOperator Good afternoon, and welcome to the OPKO Health first-quarter 2025 financial results conference call. (Operator Instructions)

OPKO Health's strategic sale to Labcorp aims to bolster profitability and streamline operations. The company's revenue guidance projects a strong outloo

OPKO Health, Inc. (NASDAQ:OPK) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ETCompany ParticipantsYvonne Briggs - Alliance Advisors IRDr.

Conference call begins at 4:30 p.m. Eastern time today MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. ( OPK) reports business highlights and fi

Revenue: Reported $149.9 million for Q1 2025, falling short of the estimated $164.26 million.Earnings Per Share (EPS): Recorded a net loss of $0.10 per share,

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Charles T. Todd, Jr. named CEO and Chair of the Board MIAMI, FLORIDA / ACCESS Newswire / April 23, 2025 / Ludwig Enterprises, Inc. (the "Company"), has appointe

Summary OPKO Health Inc (OPK), a multinational biopharmaceutical and diagnostics company, has announced that it will release its financial results for the first

MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. ( OPK) plans to report operating and financial results for the three months ended March 31, 2025 a

PR NewswireCOCONUT GROVE, Fla., April 11, 2025 The Company Expects the Continued Sale of OPKO-Branded Products in China but is Pausing Activities for Futur

On April 4, 2025, OPKO Health Inc (OPK), a multinational biopharmaceutical and diagnostics company, announced that its Board of Directors has authorized an addi

MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. ( OPK) today announced that its Board of Directors has authorized an increase of $100 million to t

Hedge Fund Icon Ray Dalio Explains Tariffs In Simple Terms We Can All Understand (The Basis Point) Hedge Fund Boss Paul Marshall Bet Big On Elon Musk Before Trump’s Election (Desmog.